treatment
strategi
consid
possibl
treatment
stockpil
may
limit
analyz
effect
vari
percentag
infect
receiv
treatment
outcom
peak
absente
differ
r
prophylaxi
strategi
assum
treatment
stockpil
would
larg
enough
ensur
suffici
treatment
dose
avail
plan
use
prophylaxi
also
explor
scenario
although
prophylaxi
stockpil
fix
certain
quantiti
proport
hcw
may
develop
clinic
ill
either
start
prophylaxi
clinic
infect
hcw
identifi
pandem
influenza
infect
would
need
continu
receiv
prophylaxi
result
prophylaxi
dose
may
save
save
dose
may
potenti
redistribut
nonclin
infect
hcw
prolong
prophylaxi
beyond
plan
durat
exampl
origin
stockpil
week
prophylaxi
hcw
could
stop
prophylaxi
clinic
infect
prior
start
prophylaxi
dose
could
save
redistribut
hcw
prolong
durat
prophylaxi
beyond
origin
week
perform
analys
explor
scenario
although
possibl
test
promptli
confirm
individu
infect
logist
network
allow
prompt
redistribut
address
issu
anoth
angl
explor
number
prophylaxi
dose
use
end
plan
durat
prophylaxi
variou
scenario
base
r
clinic
infect
identifi
prophylaxi
stop
total
amount
oseltamivir
use
also
analyz
assumpt
hcw
consum
prophylaxi
preplan
durat
ignor
effect
hand
death
prophylaxi
dose
may
save
clinic
infect
hcw
prophylaxi
receiv
treatment
dose
drawn
treatment
stockpil
transmiss
dynam
play
import
role
determin
growth
epidem
shape
epidem
curv
turn
determin
overal
epidem
durat
peak
absente
similar
anoth
model
studi
assum
onset
symptom
coincid
onset
infecti
ie
incub
period
coincid
latent
period
actual
differ
time
durat
probabl
less
day
influenza
sinc
symptom
start
day
detect
viral
shed
henc
assum
valu
correspond
symbol
describ
incub
latent
period
studi
base
case
assum
latentincub
period
day
infecti
period
day
similar
base
case
valu
use
mill
et
al
estim
r
pandem
gener
set
epidem
rang
growth
rate
chang
r
base
latent
infecti
period
lower
r
less
impact
mistim
prophylaxi
less
issu
sinc
overal
peak
absente
low
higher
r
epidem
progress
quickli
week
durat
prophylaxi
stockpil
suffici
achiev
intend
effect
key
scenario
concern
r
mistim
prophylaxi
substanti
exacerb
effect
outcom
scenario
week
prophylaxi
either
subtanti
less
effect
reduc
peak
absente
compar
treatment
sensit
analys
henc
focuss
combin
scenario
outcom
variabl
analys
includ
pandem
durat
peak
staff
absente
day
absente
focus
attent
peak
staff
absente
sensit
analys
marker
comparison
pandem
impact
busi
continu
influenc
outcom
number
day
absente
vari
peak
absente
pandem
durat
depend
r
provid
independ
comparison
across
scenario
paramet
relat
diseas
sever
antivir
efficaci
previous
studi
paramet
oneway
sensit
analysi
perform
determin
impact
outcom
perform
separ
oneway
sensit
analysi
differ
combin
r
manag
strategi
action
treatment
prophylaxi
combin
r
manag
strategi
affect
outcom
vari
input
paramet
certain
input
paramet
efficaci
prophylaxi
effect
treatment
applic
strategi
treatment
action
therefor
exclud
analys
respect
strategi
facilit
interpret
effect
prophylaxi
present
result
sustain
prophylaxi
entir
pandem
durat
hospit
case
fatal
rate
scale
togeth
base
distribut
upper
lower
limit
fix
variabl
distribut
center
mean
hospit
case
fatal
rate
like
correl
pandem
addit
mont
carlo
simul
analys
iter
per
scenario
perform
rang
diseas
sever
antivir
efficaci
paramet
estim
model
triangular
distribut
result
base
case
scenario
shown
figur
main
manuscript
present
median
th
th
percentil
base
variou
r
strategi
paramet
pertain
transmiss
dynam
analyz
separ
valu
futur
predict
whose
distribut
predict
exisit
studi
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
sensit
analys
base
multipl
scenario
also
perform
determin
variat
hcwtohcw
patienttohcw
transmiss
affect
outcom
explor
oneway
sensit
analys
paramet
outcom
peak
absente
time
peak
absente
introduct
first
case
gener
popul
explor
combin
effect
vari
patienttohcw
hcwtohcw
transmiss
paramet
simultan
twoway
sensit
analys
address
concern
differ
combin
latent
infecti
period
may
affect
result
conduct
sensit
analysi
differ
latent
infecti
period
use
howev
growth
rate
epidem
determin
reproduct
potenti
well
gener
time
infecti
agent
ie
time
take
produc
sucess
gener
case
exampl
epidem
caus
infecti
agent
r
gener
time
day
would
grow
rate
epidem
r
gener
time
day
account
defin
set
epidem
base
growth
rate
correspond
r
latent
period
day
infecti
period
day
recalcul
correspond
r
differ
paramet
choic
amd
base
equat
given
mill
et
al
equat
reproduc
use
chosen
notat
growth
rate
latent
infecti
period
model
broad
rang
latent
infecti
period
tabl
main
manuscript
figur
explor
suffici
treatment
stockpil
differ
r
outcom
vari
percentag
infect
individu
receiv
treatment
due
limit
stockpil
lie
progress
outcom
action
full
treatment
infect
hcw
tabl
compar
peak
absente
hcw
prophylaxi
redistribut
without
redistribut
fix
preplan
durat
prophylaxi
dose
redistribut
prophylaxi
dose
none
margin
effect
scenario
reduc
peak
absente
tabl
show
number
prophylaxi
dose
use
end
plan
durat
prophylaxi
variou
scenario
base
r
lower
r
shorter
predetermin
durat
prophylaxi
week
prophylaxi
stock
utilis
end
predetermin
durat
prophylaxi
higher
r
longer
predetermin
durat
prophylaxi
week
less
stock
use
redistribut
prophylaxi
reduc
peak
absenteesim
tabl
sinc
preplan
durat
would
alreadi
adequ
import
scenario
scenario
increment
increas
prophylaxi
durat
result
sharp
decreas
peak
absente
shown
tabl
prophylaxi
dose
util
remain
tabl
show
treatment
prophylaxi
dose
requir
variou
strategi
base
case
scenario
r
prophylaxi
dose
constitut
overwhelm
major
dose
requir
prophylaxi
strategi
week
number
treatment
dose
requir
decreas
longer
durat
prophylaxi
number
treatment
dose
save
differ
prophylaxi
strategi
rel
neglig
consid
number
prophylaxi
dose
requir
diseas
sever
antivir
efficaci
paramet
follow
result
scenario
valu
r
viabl
strategi
week
prophylaxi
focus
substanti
impact
outcom
figur
show
result
oneway
sensit
analys
differ
combin
r
manag
strategi
regardless
valu
r
given
strategi
outcom
sensit
paramet
strategi
action
day
medic
leav
without
treatment
symptomat
proport
infect
person
without
prophylaxi
substanti
effect
outcom
day
medic
leav
without
treatment
variat
baselin
outcom
depend
r
symptomat
proport
infect
person
without
prophylaxi
variat
outcom
insensit
hospit
casefat
length
hospit
symptomat
infect
treatment
strategi
sensit
reduct
medic
leav
oseltamivir
treatment
addit
day
medic
leav
without
treatment
symptomat
proport
infect
person
without
prophylaxi
day
medic
leav
without
treatment
variat
baselin
outcom
depend
r
reduct
medic
leav
treatment
variat
symptomat
proport
infect
person
without
prophylaxi
variat
outcom
insensit
input
paramet
prophylaxi
strategi
also
sensit
efficaci
antivir
use
prophylaxi
oseltamivir
efficaci
prevent
infect
expos
person
oseltamivir
efficaci
prevent
diseas
infect
person
oseltamivir
efficaci
prevent
transmiss
infect
infect
person
addit
factor
treatment
oseltamivir
efficaci
prevent
diseas
infect
person
variat
baselin
outcom
depend
r
oseltamivir
efficaci
prevent
infect
expos
person
variat
oseltamivir
efficaci
prevent
transmiss
infect
infect
person
variat
day
medic
leav
without
treatment
variat
reduct
medic
leav
treatment
variat
symptomat
proport
infect
person
without
prophylaxi
variat
outcom
insensit
input
paramet
tabl
give
multiway
sensit
analysi
use
montecarlo
simul
iter
diseas
sever
antivir
efficaci
paramet
r
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
week
prophylaxi
provid
result
suffici
close
provid
prophylaxi
throughout
entir
pandem
lower
r
prophylaxi
week
provid
better
outcom
compar
action
necessarili
treatment
outcom
action
treatment
subject
greater
spread
uncertainti
adequ
prophylaxi
basecas
scenario
r
figur
main
manuscript
week
prophylaxi
margin
advantag
treatment
week
clear
advantag
treatment
paramet
pertain
transmiss
dynam
tabl
show
transmiss
dynam
paramet
affect
intens
transmiss
within
hcw
popul
well
time
hcw
epidem
baselin
patienttohcw
transmiss
even
small
increment
patienttohcw
transmiss
potenti
increas
peak
absente
hcw
tabl
effect
howev
satur
higher
valu
hp
regard
epidem
time
patienttohcw
transmiss
minim
hp
hcw
epidem
peak
time
peak
gener
popul
increas
hp
ratio
shift
hcw
epidem
forward
preced
gener
popul
extrem
valu
hp
hcw
epidem
peak
start
hcw
prophylaxi
occur
hp
base
case
paramet
therefor
subsequ
analys
use
valu
hp
shown
tabl
chang
extent
transmiss
attribut
hcwtohcw
contact
minim
effect
peak
absente
time
hcw
epidem
figur
show
combin
effect
vari
patienttohcw
hcwtohcw
transmiss
paramet
simultan
twoway
sensit
analys
relev
combin
patienttohcw
hcwtohcw
transmiss
shown
r
week
prophylaxi
suffici
least
margin
superior
treatment
week
prophylaxi
clearli
superior
treatment
strategi
pandem
shorter
durat
either
entir
popul
higher
r
within
hcw
popul
increas
hp
ratio
shorter
durat
prophylaxi
superior
treatment
reduct
peak
absente
week
prophylaxi
effect
week
prophylaxi
pandem
longer
durat
lower
r
decreas
hp
ratio
prophylaxi
inferior
treatment
r
lower
hp
even
week
prophylaxi
insuffici
howev
longer
durat
pandem
overal
peak
absente
alreadi
low
latent
infecti
period
figur
main
manuscript
show
peak
absente
differ
treatment
prophylaxi
strategi
vari
rate
growth
latent
period
infecti
durat
centr
set
figur
base
case
paramet
low
growth
rate
although
situat
inadequ
prophylaxi
like
peak
absente
low
regardless
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
strategi
chosen
rel
insensit
choic
prophylaxi
durat
higher
growth
rate
peak
absente
week
prophylaxi
equal
superior
treatment
alon
week
alway
substanti
superior
figur
optim
result
treatment
strategi
possibl
even
without
stockpil
treatment
dose
hcw
reason
firstli
proport
hcw
remain
uninfect
pandem
proport
depend
r
decreas
increas
r
larger
number
secondari
infect
addit
infect
hcw
would
asymptomat
basecas
assumpt
requir
treatment
final
achiev
suppress
peak
absente
treatment
stockpil
need
cover
slightli
past
epidem
peak
treatment
tail
end
epidem
effect
peak
exampl
base
case
pandem
r
stockpil
hcw
would
suffici
achiev
optim
result
figur
howev
pandem
prepared
plan
guard
possibl
spread
would
includ
possibl
nd
rd
wave
absenc
effect
vaccin
increas
infect
rate
highrisk
subpopul
hcw
assum
suffici
treatment
dose
avail
plan
current
prophylaxi
strategi
prophylaxi
alway
stock
avail
treatment
may
necessit
treatment
coverag
hcw
result
appar
prophylaxi
must
cover
pandem
peak
achiev
reduct
peak
absente
treatment
strategi
pandem
higher
r
week
less
durat
stockpil
week
would
cover
entir
pandem
durat
addit
stockpil
situat
accru
addit
benefit
increas
cost
protect
hcw
worstcas
scenario
pandem
high
r
fast
spread
high
peak
absente
prophylaxi
strategi
week
effect
shield
hcw
major
infect
occur
gener
popul
leav
provid
critic
healthcar
servic
pandem
peak
circumst
redistribut
prophylaxi
extend
prophylaxi
durat
beyond
predetermin
durat
substanti
effect
peak
absenteesim
tabl
util
prophylaxi
dose
import
scenario
mention
scenario
util
fall
major
infect
taken
place
end
predetermin
prophylaxi
durat
situat
redistribut
prophylaxi
dose
substanti
impact
absente
pandem
peak
pass
current
pandem
plan
call
distribut
consumpt
prophylaxi
specifi
durat
clinic
influenza
infect
easili
determin
given
presenc
influenzalik
ill
even
laboratori
test
requir
time
develop
distribut
save
prophylact
dose
may
small
number
hcw
death
prophylaxi
fact
everi
hcw
develop
clinic
ill
prophylaxi
dose
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
save
prophylaxi
stockpil
draw
entir
treatment
cours
separ
treatment
stockpil
durat
prophylaxi
hcw
therefor
use
repres
strategi
per
current
pandem
prepared
protocol
present
conserv
scenario
stockpil
maxim
util
although
shown
either
method
util
result
similar
conclus
oneway
sensit
analys
figur
input
paramet
reduct
medic
leav
treatment
paramet
pertain
effect
prophylaxi
substanti
impact
outcom
show
outcom
peak
absente
sensit
treatment
prophylaxi
strategi
consid
studi
shown
tabl
treatment
alway
superior
action
alway
consid
prepared
plan
howev
insuffici
durat
prophylaxi
detriment
compar
treatment
depend
assumpt
transmiss
dynam
diseas
sever
antivir
efficaci
low
r
pandem
long
durat
tend
render
prophylaxi
insuffici
howev
pandem
slow
pickup
epidem
curv
rel
low
peak
absente
may
allow
polici
maker
choos
appropri
strategi
base
initi
surveil
data
tabl
chang
proport
transmiss
attribut
hcwtohcw
spread
minim
effect
peak
absente
time
hcw
epidem
diseas
transmiss
among
hcw
depend
hcwtohcw
spread
well
acquisit
diseas
gener
popul
two
mode
spread
correl
appendix
increas
one
proport
decreas
possibl
negat
effect
chang
addit
increas
peak
absente
resid
patienttohcw
spread
turn
depend
amount
protect
provid
hcw
infect
control
person
protect
equip
may
thu
import
aspect
hcw
protect
pandem
figur
reinforc
fact
pandem
shorter
durat
shorter
durat
prophylaxi
effect
suffici
cover
pandem
durat
pandem
shorter
durat
high
peak
absente
impact
greatest
prophylaxi
strategi
effect
final
differ
estim
latent
infecti
period
determin
whether
conclus
would
affect
differ
latent
infecti
period
assum
fix
growth
rate
epidem
see
even
broad
rang
epidem
scenario
even
extrem
choic
valu
latent
period
infecti
period
would
littl
impact
conclus
figur
main
manuscript
polici
maker
must
consid
stockpil
suffici
antivir
treat
clinic
infect
hcw
addit
polici
maker
consid
prophylaxi
risk
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
manag
perspect
sever
pandem
increas
strain
hcw
due
number
patient
hospit
reduc
respons
capac
healthcar
servic
polici
therefor
consid
protect
high
impact
pandem
short
durat
high
morbid
mortal
high
peak
absente
pandem
prophylaxi
durat
week
effect
across
rang
scenario
shown
studi
safe
amount
prophylaxi
avail
critic
worker
rel
small
compar
strategi
entir
countri
invest
may
costbenefici
sinc
critic
function
sacrif
prepar
worstcas
scenario
actual
pandem
may
prolong
lower
impact
pandem
lesser
sever
probabl
place
fewer
requir
essenti
servic
studi
show
pandem
also
result
lower
absente
rate
treatment
prophylaxi
less
critic
servic
continu
pandem
polici
maker
suffici
time
reconsid
option
pandem
polici
maker
must
also
consid
addit
prevent
measur
addit
antivir
drug
public
health
infect
control
measur
must
emphas
togeth
antivir
use
supersed
treatment
prophylaxi
strategi
final
surveil
network
import
ensur
appropri
strategi
adopt
base
project
epidem
curv
earli
pandem
phase
polici
maker
must
inform
untim
prophylaxi
detriment
outcom
prophylaxi
initi
held
back
certain
point
epidem
curv
prophylaxi
substanti
impact
cover
pandem
peak
although
may
difficult
given
public
sentiment
pressur
prematur
initi
may
render
prophylaxi
less
ineffect
inform
acquir
surveil
influenc
polici
decis
appropri
studi
need
determin
ideal
time
prophylaxi
initi
role
surveil
evalu
pandem
phase
project
spread
prophylaxi
initi
prematur
treatment
may
better
option
reduc
absente
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
r
mortal
hospit
set
ratio
hospit
rate
case
fatal
rate
tabl
tabl
prophylaxi
dose
util
end
predetermin
prophylaxi
period
assumpt
prophylaxi
redistribut
number
prophylaxi
dose
use
end
predetermin
prophylaxi
period
total
prophylaxi
stockpil
week
prophylaxi
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
figur
oneway
sensit
analysi
strategi
treatment
r
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
figur
oneway
sensit
analysi
strategi
prophylaxi
materi
provid
author
supplement
effect
neuraminidas
inhibitor
prevent
staff
absente
pandem
influenza
mar
part
emerg
infecti
diseas
content
